President: Tomohiro Morio, MD, PhD
Chair, The 2nd International Symposium of Clinical Immunology
Vice President, The Japanese Society of Clinical Immunology
Professor, Department of Pediatrics and Developmental Biology,
Tokyo Medical and Dental University (TMDU)
The Japanese Society of Clinical Immunology (JSCI) was established in 1973 with the aim of advancing and developing clinical immunology and related fields and has continued its activities under the theme of "Cross-sectional immunology aimed at breakthroughs in disease controls".
Clinical immunology covers a wide range of fields such as basic immunology, internal medicine, pediatrics, collagen disease, rheumatism, oncology, gastroenterology, nephrology, neurology, infectious diseases, allergies, dermatology, obstetrics， gynecology, and ophthalmology. It is a cross-cutting, multi-layered study. With the global spread of COVID-19, the clinical application of basic immunology is gaining more global attention, and global knowledge sharing and cooperation are essential.
In January 2021, the Japanese Society for Clinical Immunology officially joined the Federation of Clinical Immunology Societies (FOCIS) as a member society and hosted the symposium organized by the JSCI within the framework of the annual meeting of the federation. We are expanding our network. Taking this opportunity, we decided to host the first International Symposium of Clinical Immunology (ISCI) in 2022.
It is my great pleasure and honor to serve as the chair of the second ISCI in 2023 in Kamakura City, a beautiful city with a long history, and 250 people from Japan and abroad are expected to participate. Dramatic advances in technological innovation have led to the successive elucidation of human immune response mechanisms. Keeping these research findings in mind, the 2nd ISCI is planning a program that will cover everything from the elucidation of molecular pathogenesis to study on cutting-edge targeted therapies. Sophisticated genome analysis and multilayered analysis of disease models in human subjects have become indispensable methods. We hope to share and discuss the latest findings on clinical immunology arising from the integration of multi-omics data and clinical data, including the establishment of disease registries.
The 2nd ISCI will be held in a hybrid format of in-person and online participation. We hope that many clinicians and researchers from Japan and abroad will participate in the meeting and we look forward to enthusiastic discussions that will lead to many breakthroughs.
